肺动脉高压治疗中右心室功能的恢复
本研究纳入127例初治成人肺动脉高压患者,以右心室射血分数(RVEF)45%为阈值分组,评估治疗反应及预后。随访时75例(60%)达到或维持RVEF≥45%,该阈值与长期右心室功能稳定及更优生存相关。
要点
- 基线RVEDV和NT-proBNP是多变量预测随访RVEF≥45%的指标。
- PVR降低40%带来更大RVEF改善,但不保证RVEF≥45%。
- 随访未达RVEF≥45%者后续多持续低于该阈值。
核心结论
- PAH患者起始治疗后60%达到或维持RVEF 45%阈值,与长期右心室功能稳定和良好预后相关。
研究设计与样本
- 纳入127例初治成人PAH患者,基线及首次随访行心脏磁共振,随访至删失或死亡/肺移植。
主要发现
- 随访时75例达到或维持RVEF≥45%,52例未达到。
- 基线RV舒张末期容积和NT-proBNP是多变量预测随访RVEF≥45%的指标。
- PVR降低40%者RVEF改善更大(ΔRVEF 17±11 vs. 5±8;交互P<0.001),但不保证RVEF≥45%。
- RVEF 45%阈值与长期右心室功能稳定及更好生存相关(HR 1.91,95%CI 1.11-3.27)。
- 首次随访未达RVEF≥45%者,后续多次随访多持续低于该阈值。
关键数值与推荐
- RVEF 45%为临床相关阈值。
- PVR降低40%为分组界值。
临床怎么用
- 可将RVEF 45%作为PAH治疗随访中评估右心室功能恢复与预后的参考阈值。
- 基线RVEDV和NT-proBNP有助于预判随访时能否达到RVEF≥45%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A 45% threshold of right ventricular ejection fraction (RVEF) is proposed clinically relevant in patients with pulmonary arterial hypertension (PAH). We aim to determine treatment response, long-term right ventricular (RV) functional stability and prognosis of patients with PAH reaching or maintaining the RVEF 45% threshold. METHODS: Incident, treatment-naive, adult PAH patients with cardiac magnetic resonance imaging at baseline and first follow-up were included (total N=127) and followed until date of censoring or death/lung transplantation. Patients were categorised into two groups based on 45% RVEF. Baseline predictors, treatment response and prognosis were assessed with logistic regression analyses, two-way analysis of variance and log-rank tests. RESULTS: Patients were 50±17 years old, 73% female, of which N=75 reached or maintained the 45% RVEF threshold at follow-up (RVEF≥45%@FU), while N=52 patients did not (RVEF<45%@FU). RV end-diastolic volume and N-terminal pro-B-type natriuretic peptide at baseline were multivariable predictors of an RVEF ≥45% at follow-up. A 40% pulmonary vascular resistance (PVR) reduction resulted in greater improvement in RV function (ΔRVEF 17±11 vs. 5±8; pinteraction<0.001) compared to a PVR reduction <40%, but did not guarantee an RVEF ≥45%. Finally, the 45% RVEF threshold was associated with stable RV function during long-term follow-up and better survival (HR: 1.91 (95% CI: 1.11 to 3.27)). Patients failing to reach or maintain the 45% RVEF threshold at first follow-up mostly stayed below this threshold over the next consecutive visits. CONCLUSION: After treatment initiation, 60% of patients with PAH reach or maintain the 45% RVEF threshold, which is associated with a long-term stable RV function and favourable prognosis.
引用
- Celant LR, Wessels JN, Kianzad A, et al. Restoration of right ventricular function in the treatment of pulmonary arterial hypertension. Heart. 2023. PMID: 37527919. doi:10.1136/heartjnl-2023-322742
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。